Emergency Department Management of Patients With Febrile Neutropenia: Guideline Concordant or Overly Aggressive?
The Infectious Diseases Society of America and the American Society of Clinical Oncology recommend risk stratification of patients with febrile neutropenia (FN) and discharge with oral antibiotics for low-risk patients. We studied guideline concordance and clinical outcomes of FN management in our emergency department (ED).



Our urban, tertiary care teaching hospital provides all emergency and inpatient services to a large comprehensive cancer center. We performed a structured chart review of all FN patients seen in our ED from January 2010 to December 2014. Using electronic medical records, we identified all visits by patients with fever and an absolute neutrophil count of <1000 cells/mm3and then included only patients without a clear source of infection. Following national guidelines, we classified patients as low or high risk and assessed guideline concordance in disposition and parenteral versus oral antibiotic therapy by risk category as our main outcome measure.



Of 173 qualifying visits, we classified 44 (25%) as low risk and 129 (75%) as high risk. Management was guideline concordant in 121 (70%, 95% confidence interval [CI] = 63% to 77%). Management was guideline discordant in 43 (98%, 95% CI = 88% to 100%) of low-risk patients versus 9 (7%, 95% CI = 3% to 13%) of high-risk patients (relative risk [RR] = 14, 95% CI = 7.5 to 26). Of 52 guideline-discordant cases, 36 (83%, 95% CI = 72% to 93%) involved low-risk cases with treatment that was more aggressive than recommended.



Guideline concordance was low among low-risk patients, with management tending to be more aggressive than recommended. Unless data emerge that undermine the guidelines, we believe that many of these hospitalizations and parenteral antibiotic regimens can be avoided, decreasing the risks associated with hospitalization, while improving antibiotic stewardship and patient comfort.
The Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA.
Christopher W
CW
Baugh
Harvard Medical School, Boston, MA.
Thomas J
TJ
Wang
The Department of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH.
Jeffrey M
JM
Caterino
The Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA.
Olesya N
ON
Baker
The Gastrointestinal Cancer Center, Dana Farber Cancer Institute, Boston, MA.
Gabriel A
GA
Brooks
The Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA.
Audrey C
AC
Reust
The Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA.
Daniel J
DJ
Pallin
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D057286:Electronic Health Records; D004636:Emergency Service, Hospital / Q000592:standards*; D064147:Febrile Neutropenia / Q000145:classification / Q000150:complications / Q000628:therapy*; D005260:Female; D005334:Fever / Q000188:drug therapy; D019983:Guideline Adherence / Q000706:statistics & numerical data*; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications; D017410:Practice Guidelines as Topic; D012189:Retrospective Studies; D018570:Risk Assessment
D000900:Anti-Bacterial Agents